Capital Grand Est

Sirfull Technology is a software company based in Schiltigheim, France, specializing in welding quality and equipment life cycle management. It develops cloud-based software solutions, including VDB, which manages welding quality control and technical documentation, and IRM, an equipment inspection platform that integrates inspection, monitoring, and risk management for industrial equipment. These tools are designed to optimize business processes by centralizing information on a collaborative platform. Sirfull Technology serves a range of industries, including oil and gas, chemical, pharmaceutical, and energy sectors. In addition to its software offerings, the company provides technical outsourcing and integration services, with products available as Software-as-a-Service or for installation on PC or server systems.

Exeliom is a clinical-stage biopharmaceutical company based in Dijon, France, focused on developing innovative microbial therapies that utilize commensal bacteria as therapeutic agents. Founded in 2016, Exeliom aims to unlock the therapeutic potential of gut microbiota to enhance health and longevity. The company specializes in creating a new class of medicines known as Live Biotherapeutics, which are designed to deliver microbiome-based immunotherapy for conditions such as inflammatory bowel diseases and cancer, with an initial focus on Crohn's Disease. By harnessing the role of microbiota in the immune system, Exeliom strives to provide patients with advanced treatments that improve their quality of life.

Braintale is a Paris-based company founded in 2018 that specializes in developing and distributing innovative diagnostic and prognostic tools specifically for brain-injured patients. The company's digital medical care platform is designed for hospitals to effectively analyze MRI reports, providing accessible solutions that meet the needs of healthcare professionals and patients alike. Braintale’s products are grounded in over 15 years of clinical development, focusing on predicting patient outcomes, particularly for those in comas due to severe traumatic brain injuries, cardiac arrests, or hemorrhagic strokes. By facilitating easier diagnoses, Braintale aims to enhance patient care in critical settings, ultimately improving the prognosis for individuals with severe brain injuries.